This study utilized the precious clinical specimens sequenced by NGS and Big Data analysis via bioinformatics to elucidate a possible candidate gene, ADAMTS8, and provide a potential strategy for patients who have not benefited from TKIs or ICIs in lung cancer treatment. This evidence concerns the gene ADAMTS8 and lung cancer.